Luis Leyva, MD
Obstetrics & Gynecology · Miami, FLNPI 1669417366
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,670 of the $4,958 with a category attached, or 74.0%. 26 manufacturers reported payments, led by Modernatx, Inc. at 36.2% of the total. Reporting peaked in 2023 at $2,467 and has fallen 79.7% since, to $501 in 2025.
Across 139 payments — averaging $35.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$2K
- Hologic Sales And Service, LLC$770
- AbbVie$729
- Mayne Pharma Commercial LLC$411
- Astellas Pharma US Inc$298
- Millicent US Inc$120
- plus $835 from 20 others
Across 189 payments — averaging $3965.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$710K
- Astellas Pharma Global Development$40K
What the payments were for
- Travel & lodging$1,27526%
- Food & beverage$3,67074%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 6 | $1,796 |
| Hologic Sales And Service, LLC | 23 | $770 |
| AbbVie(2 entities) | 43 | $729 |
| Mayne Pharma Commercial LLC | 8 | $411 |
| Astellas Pharma US Inc | 10 | $298 |
| Millicent US Inc | 6 | $120 |
| Bayer | 6 | $111 |
| Medicem Inc. | 2 | $102 |
| Daiichi Sankyo Inc. | 5 | $99 |
| Pfizer | 4 | $77 |
| Myovant Sciences Inc. | 3 | $69 |
| Therapeuticsmd, Inc. | 3 | $59 |
| Roche Diagnostics Corporation | 2 | $40 |
| Organon | 4 | $38 |
| Avion Pharmaceuticals | 3 | $37 |
| Biogen | 1 | $28 |
| Duchesnay USA Incorporated | 1 | $27 |
| Exeltis, USA Inc. | 1 | $21 |
| Agile Therapeutics, Inc. | 1 | $18 |
| Axonics, Inc. | 1 | $18 |
| Bard Peripheral Vascular, Inc. | 1 | $17 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| Evofem Biosciences, Inc. | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACESSA PROVU SYSTEM$297
- Veozah$125
- ORIAHNN$124
- NEXTSTELLIS$122
- BIJUVA$122
How this compares
$4,958 in reported general payments places this provider in the 85th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 27 | $1,812 |
| Estradiol (Twice Weekly)Estradiol | 16 | $1,399 |
| Alendronate Sodium | 16 | $100 |
| Fluconazole | 11 | $36 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Miami
- Youssef MouhayarMiami$162K
- Rebeca MartinezMiami$108K
- Jason JamesMiami$97K
- Peter KhamvongsaMiami$67K
- Abdulrahman SinnoMiami$67K
- Ingrid ParedesMiami$65K
- Karen Salazar ValdesMiami$29K
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.